[go: up one dir, main page]

KR900700136A - 특정 paf 길항제/항히스타민제 조성물 - Google Patents

특정 paf 길항제/항히스타민제 조성물

Info

Publication number
KR900700136A
KR900700136A KR1019890702438A KR890702438A KR900700136A KR 900700136 A KR900700136 A KR 900700136A KR 1019890702438 A KR1019890702438 A KR 1019890702438A KR 890702438 A KR890702438 A KR 890702438A KR 900700136 A KR900700136 A KR 900700136A
Authority
KR
South Korea
Prior art keywords
certain
paf antagonist
compositions
antihistamine
antihistamine compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019890702438A
Other languages
English (en)
Other versions
KR930009786B1 (ko
Inventor
모타심 빌라 엠.
Original Assignee
쉐링 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쉐링 코포레이션 filed Critical 쉐링 코포레이션
Publication of KR900700136A publication Critical patent/KR900700136A/ko
Application granted granted Critical
Publication of KR930009786B1 publication Critical patent/KR930009786B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1019890702438A 1988-04-27 1989-04-24 특정 paf 길항제/항히스타민제 조성물 Expired - Fee Related KR930009786B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18653588A 1988-04-27 1988-04-27
US186,535 1988-04-27
PCT/US1989/001671 WO1989010143A1 (en) 1988-04-27 1989-04-24 Certain paf antagonist antihistamine combinations and methods

Publications (2)

Publication Number Publication Date
KR900700136A true KR900700136A (ko) 1990-08-11
KR930009786B1 KR930009786B1 (ko) 1993-10-11

Family

ID=22685331

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890702438A Expired - Fee Related KR930009786B1 (ko) 1988-04-27 1989-04-24 특정 paf 길항제/항히스타민제 조성물

Country Status (15)

Country Link
EP (2) EP0402422A1 (ko)
JP (1) JPH0655673B2 (ko)
KR (1) KR930009786B1 (ko)
AT (1) ATE84724T1 (ko)
AU (1) AU619555B2 (ko)
CA (1) CA1327316C (ko)
DE (1) DE68904475T2 (ko)
DK (1) DK255190A (ko)
ES (1) ES2044100T4 (ko)
IE (1) IE63697B1 (ko)
IL (1) IL90100A (ko)
MY (1) MY106956A (ko)
NZ (1) NZ228879A (ko)
WO (1) WO1989010143A1 (ko)
ZA (1) ZA893101B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
US6277846B1 (en) * 1990-05-31 2001-08-21 Allergan Sales, Inc. Use of platelet activating factor antagonists as anti-pruritic agents
ATE128030T1 (de) * 1990-08-02 1995-10-15 Hoffmann La Roche Antiallergische mischung.
US5227378A (en) * 1990-08-02 1993-07-13 Hoffmann-La Roche Inc. Combination of PAF antagonists and LTD4 antagonists for the treatment of allergic reactions
FR2673842B1 (fr) * 1991-03-13 1993-12-24 Rhone Poulenc Rorer Sa Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP3060287B2 (ja) * 1995-10-09 2000-07-10 参天製薬株式会社 アパファントを主薬とする水性点眼剤
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
NZ211146A (en) * 1984-02-29 1987-10-30 Merck & Co Inc 2,5-diaryl-tetrahydrothiophene derivatives and pharmaceutical compositions
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Also Published As

Publication number Publication date
EP0402422A1 (en) 1990-12-19
WO1989010143A1 (en) 1989-11-02
DK255190D0 (da) 1990-10-23
IE63697B1 (en) 1995-05-31
CA1327316C (en) 1994-03-01
IE891362L (en) 1989-10-27
JPH03502097A (ja) 1991-05-16
IL90100A (en) 1995-01-24
AU3578289A (en) 1989-11-24
EP0345931A1 (en) 1989-12-13
ES2044100T4 (es) 1996-07-16
NZ228879A (en) 1992-08-26
DK255190A (da) 1990-10-23
JPH0655673B2 (ja) 1994-07-27
EP0345931B1 (en) 1993-01-20
DE68904475D1 (de) 1993-03-04
DE68904475T2 (de) 1993-05-13
ATE84724T1 (de) 1993-02-15
AU619555B2 (en) 1992-01-30
MY106956A (en) 1995-08-30
ZA893101B (en) 1989-12-27
KR930009786B1 (ko) 1993-10-11
ES2044100T3 (es) 1994-01-01
IL90100A0 (en) 1989-12-15

Similar Documents

Publication Publication Date Title
DE3885816D1 (de) Mischungen von Polycarbonat und von Siloxan-Polyetherimid-Copolymer.
DE68920529D1 (de) Blockcopolymere und Zusammensetzungen davon.
FI882791A7 (fi) Aineita, jotka parantavat määrättyjen 1,4-dihydropyridiinijohdannaisten siirtymistä ihon läpi.
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
DE3889091D1 (de) Härtbare Zusammensetzung von Oxyalkylenpolymeren.
ATE107130T1 (de) Zusammensetzung und ihre verwendung.
DE69022567D1 (de) Polycarbonat-polydimethylsiloxan copolymer und herstellungsverfahren.
DE3871751D1 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
DE68922366D1 (de) Piperidinyl-Benzimidazole als Antihistaminica.
DE69014213D1 (de) Bit-Planmodifikation.
FI915970A7 (fi) Lääkkeitä, jotka ovat hyödyllisiä syövän hoidossa ja joilla on antihis tamiiniominaisuuksia
DE3873616D1 (de) Polyacetal-harzzusammensetzung und daraus hergestellte gleitteile.
DE68919311D1 (de) Selbstinduzierte Reparatur von Leiterzügen.
DE3866038D1 (de) Bohrer und zugehoeriger schneideinsatz.
DE68906345D1 (de) Antimalariazusammenstellungen, gebrauchmachend von quinidin, artemisinin und ihren derivaten.
KR900700136A (ko) 특정 paf 길항제/항히스타민제 조성물
DE58902290D1 (de) Sauerstoffabsorptionsmittel und verwendung desselben.
DE3887345D1 (de) Fluoriertes copolymer und sperrschichten.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
DE69432590D1 (de) 1,2,3,4-tetrahydrochinolin-2,3,4-trion-3 oder 4-oxime und ihre verwendung
ATE109465T1 (de) 4-aryl-4-piperidine (oder -pyrrolidin- oder - hexahydroazepin-) carbinole und heterocyclische analoga davon.
ATE51229T1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
DE69012882D1 (de) Herstellung von Stickstoffzusammensetzungen.
DE69022171D1 (de) Polyacetalkopolymer und zusammensetzungen daraus.
BR8904606A (pt) Composicao,produto endurecivel e aplicacao

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 19991005

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20001012

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20001012

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000